Identification of druggable targets from the interactome of the Androgen Receptor and Serum Response Factor pathways in prostate cancer.
Haleema Azam, Colin Veale, Kim Zitzmann, Simone Marcone, William M. Gallagher, Maria Prencipe
This study identifies common interactors of the AR/SRF crosstalk in prostate cancer as potential druggable targets through affinity purification mass spectrometry and pathway analysis.
PLoS ONE · Dec 13, 2024Peer-reviewedCancer Biology